Table 10.
Dutch cohort (115) |
Systematic biopsy |
||
---|---|---|---|
PCa/High-grade PCa | Positive | Negative | |
PI-RADS 1–2 (n = 52) | No biopsy | 14/1 | 38/51 |
PI-RADS ≥3 (n = 63): (MRI-targeted biopsy) |
Positive | 42/28 | 4/7 |
Negative | 8/1 | 9/27 |
MRI, magnetic resonance imaging; PCa, prostate cancer; PI-RADS, Prostate Imaging Reporting and Data System.